Accolade Inc (ACCD)
7.54
+0.28
(+3.86%)
USD |
NASDAQ |
May 03, 16:00
7.52
-0.02
(-0.27%)
After-Hours: 20:00
Accolade Cash from Financing (TTM): -55.57M for Feb. 29, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
February 29, 2024 | -55.57M |
November 30, 2023 | -58.15M |
August 31, 2023 | 7.117M |
May 31, 2023 | 6.106M |
February 28, 2023 | 3.163M |
November 30, 2022 | 5.432M |
August 31, 2022 | 6.505M |
May 31, 2022 | 11.49M |
February 28, 2022 | 257.93M |
Date | Value |
---|---|
November 30, 2021 | 260.29M |
August 31, 2021 | 467.22M |
May 31, 2021 | 622.95M |
February 28, 2021 | 428.38M |
November 30, 2020 | 427.95M |
August 31, 2020 | 239.04M |
May 31, 2020 | 81.26M |
February 29, 2020 | 28.22M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-58.15M
Minimum
Nov 2023
622.95M
Maximum
May 2021
161.14M
Average
28.22M
Median
Feb 2020
Cash from Financing (TTM) Benchmarks
HealthStream Inc | -13.95M |
HealthEquity Inc | -47.04M |
Trxade Health Inc | 1.406M |
Simulations Plus Inc | -3.90M |
Schrodinger Inc | 16.19M |